Use of erythropoietin

Details for Australian Patent Application No. 2003255290 (hide)

Owner EPOplus GmbH & Co. KG

Inventors Haller, Hermann; Bahlmann, Ferdinand Hermann

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003255290

PCT Number PCT/EP03/08229

PCT Pub. Number WO2004/012759

Priority 102 34 192.3 26.07.02 DE

Filing date 25 July 2003

Wipo publication date 23 February 2004

Acceptance publication date 9 April 2009

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 102 34 192.3 26.07.02 DE

1 April 2004 Application Open to Public Inspection

  Published as AU-B-2003255290

9 April 2009 Application Accepted

  Published as AU-B-2003255290

6 August 2009 Standard Patent Sealed

23 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255291-HIGH-SURFACE PRECIPITATION SILICIC ACIDS

2003255289-Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs